All In Biotech

Drug Trial Radar · NCT06338995

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants With Chronic Rhinosinusitis With Nasal Polyps on Background Intranasal Corticosteroids

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 510 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

510

Planned (sponsor's estimate)

Start

Apr 29, 2024

Primary completion

May 2027

Study completion Mar 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Apr 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.

Conditions

  • Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Interventions

  • LY3650150Drug

    Administered SC.

  • PlaceboDrug

    Administered SC.

  • Standard therapy for INCSDrug

    Administered as intranasal spray.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline (CFBL) in Participant Reported Nasal Congestion Score (NCS) SeverityTime frame: Baseline, Week 24
  2. Mean CFBL in Endoscopic Nasal Polyp Score (NPS)Time frame: Baseline, Week 24

Locations

202 sites in 20 countries. Site status is shown where the registry gives one.

  • AllerVie Clinical Research

    Birmingham, Alabama · Not yet recruiting

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Medovation Research

    Huntsville, Alabama · Recruiting

  • Novak Clinical Research - Tucson - North La Cholla Boulevard

    Tucson, Arizona · Recruiting

  • Keck Medicine of USC

    Arcadia, California · Not yet recruiting

  • University of California, Irvine

    Irvine, California · Recruiting

  • ADCRC

    La Mesa, California · Recruiting

  • Ark Clinical Research

    Long Beach, California · Recruiting

  • DaVinci Research LLC

    Roseville, California · Recruiting

  • Breathe Clear Institute

    Torrance, California · Recruiting

  • Colorado ENT & Allergy

    Colorado Springs, Colorado · Recruiting

  • Bioresearch Partner-Kendale Lakes

    Miami, Florida · Recruiting

  • Orlando ENT & Allergy

    Orlando, Florida · Not yet recruiting

  • NuLine Clinical Trial Center

    Pompano Beach, Florida · Not yet recruiting

  • University of South Florida

    Tampa, Florida · Recruiting

  • MJ Research

    Tampa, Florida · Not yet recruiting

  • Treasure Valley Medical Research

    Boise, Idaho · Recruiting

  • Entopy Research LLC

    Chicago, Illinois · Recruiting

  • Chicago ENT

    Chicago, Illinois · Recruiting

  • EMEDR

    Overland Park, Kansas · Recruiting

  • South Louisiana Ear, Nose, Throat & Facial Plastic Surgery - PPDS

    Mandeville, Louisiana · Recruiting

  • Chesapeake Clinical Research, Inc.

    White Marsh, Maryland · Recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • University of Missouri

    Columbia, Missouri · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Not yet recruiting

  • Circuit Clinical/Mercer Allergy and Pulmonary Associates

    Hamilton, New Jersey · Not yet recruiting

  • Madison ENT & Facial Plastic Surgery

    New York, New York · Recruiting

  • New York Allergy and Sinus Center

    New York, New York · Recruiting

  • Equity Medical

    The Bronx, New York · Recruiting

  • UCMC

    Cincinnati, Ohio · Not yet recruiting

  • Optimed Research, LTD

    Columbus, Ohio · Recruiting

  • Charleston ENT

    Charleston, South Carolina · Recruiting

  • Medical University of South Carolina- Department of Otolaryngology and Head and Neck Surgery

    Charleston, South Carolina · Not yet recruiting

  • Alina Clinical Trials

    Dallas, Texas · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Not yet recruiting

  • University of Texas Physicians Department of Otorhinolaryngology Clinc

    Houston, Texas · Recruiting

  • Ear Nose and Throat Associates of Texas PA

    McKinney, Texas · Recruiting

  • Alamo ENT Associates

    San Antonio, Texas · Recruiting

  • Eastern Virginia Medical School

    Norfolk, Virginia · Recruiting

  • Richmond Ear Nose and Throat

    Richmond, Virginia · Not yet recruiting

Showing 40 of 202 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.